Lack of association between RANTES-28, SDF-1 gene polymorphisms and systemic lupus erythematosus in the Malaysian population

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 2841-2850

  Lian, L H ^a   Kee, B P ^a   Ng, H L ^a   Chua, K H ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Malaysia; Polymorphism; RANTES; SDF; SLE

Indexed keywords

ADENINE; CYTOSINE; GUANINE; RANTES; STROMAL CELL DERIVED FACTOR 1; CCL5 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALAYSIAN; PATHOGENESIS; PROMOTER REGION; RANTES GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SDF 1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL; ASIAN; ETHNOLOGY; FEMALE; GENETICS; MALAYSIA; MALE; MIDDLE AGED;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL5; CHEMOKINE CXCL12; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALAYSIA; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84856477222     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.November.17.2     Document Type: Article

References (32)

1. An P, Nelson GW, Wang L, Donfield S, et al. (2002). Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. U. S. A. 99: 10002-10007.
2. Benboubker L, Watier H, Carion A, Georget MT, et al. (2001). Association between the SDF1-3' A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br. J. Haematol. 113: 247-250.
3. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, et al. (1996). A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184: 1101-1109.
4. Chew CH, Chua KH, Lian LH, Puah SM, et al. (2008). PCR-RFLP genotyping of C1q mutations and single nucleotide polymorphisms in Malaysian patients with systemic lupus erythematosus. Hum. Biol. 80: 83-93.
5. Chua KH, Kee BP, Tan SY and Lian LH (2009a). Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus. Braz. J. Med. Biol. Res. 42: 551-555.
6. Chua KH, Lau TP, Tee ZY, Tan SY, et al. (2009b). Genetic polymorphisms of the interleukin-1 beta (IL-1ß)-511 and +3954 single nucleotide polymorphisms (SNPs) in Malaysian systemic lupus erythematosus (SLE) patients. J. Health Sci. 55: 657-662.
7. Chua KH, Puah SM, Chew CH, Tan SY, et al. (2010). Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann. Hum. Biol. 37: 274-280.
8. Danchenko N, Satia JA and Anthony MS (2006). Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15: 308-318.
9. Gerli G, Vanelli C, Turri O, Erario M, et al. (2005). SDF1-3' A gene polymorphism is associated with chronic myeloproliferative disease and thrombotic events. Clin. Chem. 51: 2411-2414.
10. Hassan S, Baccarelli A, Salvucci O and Basik M (2008). Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin. Cancer Res. 14: 446-454.
11. Hizawa N, Yamaguchi E, Konno S, Tanino Y, et al. (2002). A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am. J. Respir. Crit. Care Med. 166: 686-690.
12. Hochberg MC (1985). The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum. 28: 80-86.
13. Katsiari CG and Tsokos GC (2006). Systemic lupus erythematosus: from disease pathogenesis to therapy. Drug Discov. Today Dis. Mech. 3: 185-192.
14. Liao CH, Yao TC, Chung HT, See LC, et al. (2004). Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J. Rheumatol. 31: 2062-2067.
15. Lima G, Soto-Vega E, Atisha-Fregoso Y, Sanchez-Guerrero J, et al. (2007). MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. Hum. Immunol. 68: 980-985.
16. Manetti M, Liakouli V, Fatini C, Cipriani P, et al. (2009). Association between a stromal cell-derived factor 1 (SDF-1/ CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. Ann. Rheum. Dis. 68: 408-411.
17. Ng MW, Zhou G, Chong WP, Lee LW, et al. (2007). The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect. Dis. 7: 50.
18. Nickel RG, Casolaro V, Wahn U, Beyer K, et al. (2000). Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J. Immunol. 164: 1612-1616.
19. Ortiz BD, Krensky AM and Nelson PJ (1996). Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol. Cell Biol. 16: 202-210.
20. Puah SM, Lian LH, Chew CH, Chua KH, et al. (2007). A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population. Lupus 16: 750-754.
21. Robak E, Kulczycka L, Sysa-Jedrzejowska A, Wierzbowska A, et al. (2007). Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus. Eur. Cytokine Netw. 18: 181-187.
22. Tanaka K, Roberts MH, Yamamoto N, Sugiura H, et al. (2006). Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis. Int. J. Immunogenet. 33: 423-428.
23. Tashiro K, Tada H, Heilker R, Shirozu M, et al. (1993). Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261: 600-603.
24. Wallace DJ and Hann BH (2002). Dubois' Lupus Erythematosus. 6th edn. Lippincott Williams and Wilkins, United States.
25. Wang F, Wang CL, Tan CT and Manivasagar M (1997). Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 6: 248-253.
26. Warchol T, Lianeri M, Lacki JK and Jagodzinski PP (2010). SDF1-3' G801A polymorphisms in Polish patients with systemic lupus erythematosus. Mol. Biol. Rep. 37: 3121-3125.
27. Winkler C, Modi W, Smith MW, Nelson GW, et al. (1998). Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE study, hemophilia growth and development study (HGDS), multicenter AIDS cohort study (MACS), multicenter hemophilia cohort study (MHCS), San Francisco city Cohort (SFCC). Science 279: 389-393.
28. Yao TC, Tsai YC and Huang JL (2009). Association of RANTES promoter polymorphism with juvenile rheumatoid arthritis. Arthritis Rheum. 60: 1173-1178.
29. Ye DQ, Hu YS, Li XP, Yang SG, et al. (2005a). The correlation between monocyte chemoattractant protein-1 and the arthritis of systemic lupus erythematosus among Chinese. Arch. Dermatol. Res. 296: 366-371.
30. Ye DQ, Yang SG, Li XP, Hu YS, et al. (2005b). Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus. Arch. Dermatol. Res. 297: 108-113.
31. Yeap SS, Chow SK, Manivasagar M, Veerapen K, et al. (2001). Mortality patterns in Malaysian systemic lupus erythematosus patients. Med. J. Malaysia 56: 308-312.
32. Zhernakova A, Alizadeh BZ, Eerligh P, Hanifi-Moghaddam P, et al. (2006). Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes Immun. 7: 544-549.